{
    "medicine_id": "145df6950f308ce6d0beda27736ba75b513385b4",
    "platform_id": "DB09516",
    "metadata": {
        "name": "Solage 20 mg Solution",
        "composition": "20 mg Mequinol",
        "clinical_particulars": {
            "therapeutic_indications": "Mequinol is currently primarily available only as an active ingredient in combination products combined with tretinoin that are indicated for the treatment of solar lentigines and related hyperpigmented lesions resulting from chronic sun exposure FDA Label",
            "contraindications": {
                "disease": "If a mequinol and tretinoin combination topical product is applied excessively some potential adverse effects like marked redness peeling of skin discomfort discoloration or hypopigmentation may occur FDA Label Such products are not indicated for oral ingestion FDA Label MSDS data reports that chronic exposure to a dose of 25 UMOL L in humans can result in mutagenic effects like DNA inhibition in lymphocytes MSDS",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Mequinol is in fact considered a melanocytotoxic chemical which when oxidized in melanocytes results in the formation of toxic entities like quinones L993 Such cytotoxic compounds subsequently have the potential to damage and destroy pigment cells therefore causing skin depigmentation L993 In response skin cells are naturally capable of protecting themselves against such cytotoxic agents with the help of endogenous intracellular glutathione and the detoxification action of glutathione S transferase on the cytotoxic compounds L993 Regardless it is consequently by way of this seemingly negative and damaging pharmacodynamic profile by which the mechanism of action of mequinol is sometimes described L993",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}